What You Should Know:
- Eli Lilly and Company today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month at participating retail pharmacies.
- The historic price cut makes it easier to access Lily insulin for Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable
Read More
Eli Lilly
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing
What You Should Know:
- Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market partners with Eli Lilly and Company on a new and first-to-market subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits.
- Through a flat, per-member, per-month subscription fee, employers can offer insulin to their employees with predictable, affordable, and transparent costs.
Read More
PatientsLikeMe Partners with LetsGetChecked to Offer Members Access to Home Testing Solutions
What You Should Know:
- PatientsLikeMe (PLM), the trusted community health network that empowers patients to take charge of their health, announced its partnership with LetsGetChecked, a global healthcare solutions company.
- The partnership will provide PLM’s 1 million members with access to enhanced patient support capabilities for testing. PLM’s expansive patient community can now utilize LetsGetChecked’s suite of offerings directly through the PLM platform and receive a discount on
Read More
Healthcare Companies on the Stock Market
Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system.
Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More
Eli Lilly Partners with Yseop to Expedite Drug Approval Process
What You Should Know:
- Eli Lilly and Company partners with Yseop, an AI software company and pioneer in Natural Language Processing (NLP) to deploy Yseop’s world-class enterprise automation platform, Augmented Analyst, to accelerate bringing Lilly’s medicines to patients.
- Yseop’s platform uses Natural Language Generation (NLG) to augment human analysis with automated insights. With Yseop’s powerful AI automation technology, teams can shorten the time spent on specialist medical reports
Read More
Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
What We Should Know:
- Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions.
- The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More
Livongo for Diabetes Solution Now Available to New Jersey State and School Health Plan Members
- Livongo forms partnership with Horizon Blue Cross Blue Shield of New Jersey and the State of New Jersey to provide Livongo for Diabetes to State and School Plan Members for 460k public employees and their dependents. - Livongo expects, after having been selected by the State of New Jersey in the fourth quarter of 2019, that this agreement will make approximately 29,000 people eligible for the Livongo for Diabetes program and add approximately 5,000 Members in 2020 as anticipated in the plan
Read More
Lilly to Integrate Dexcom CGMs into Personalized Diabetes Management System
- Eli Lilly has announced a global commercialization agreement to integrate Dexcom’s continuous glucose monitoring (CGM) devices into Lilly’s personalized diabetes management system. - The personalized diabetes management system, currently in development to advance the treatment of diabetes, will integrate connected insulin delivery devices, software and analysis to equip people with diabetes and their healthcare providers with personalized information and guidance to help them better manage
Read More
HealthVoyager Selected as Winner of Lilly’s Digital Health Innovation Challenge
- Lilly concluded its first digital health open innovation challenge, “Transforming IBD Care: Better Disease Monitoring, Management, and Care for People with Inflammatory Bowel Disease,” and selected HealthVoyager as the winner.- The challenge culminated in a competition hosted at Lilly’s headquarters in Indianapolis, where five finalists presented their digital health solutions aimed at transforming IBD care to a panel of judges.Eli Lilly and Company, today announced it has named HealthVoyager,
Read More
